University of Zurich: Hypertension, Pulmonary trials
The registry lists 60 Hypertension, Pulmonary studies with University of Zurich as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 5Phase 3 3Phase 4 2No phase 52(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- HAPH Registry: Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.Not yet recruitingNCT06489730
- Pulmonary Hypertension Registry SwitzerlandRecruitingNCT05610631
- Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)CompletedNCT06489756Not applicable
- Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)CompletedNCT06489743Not applicable
- High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), SDB Assessed at HA (3200 m) vs LA (760 m)CompletedNCT06489717Not applicable
- High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)CompletedNCT06489704Not applicable
- High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), 6MWT Assessed at High Altitude (3200m) vs Low Altitude (760m)CompletedNCT06489691Not applicable
- Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy in Pulmonary Vascular Disease (PVD)CompletedNCT06384534Not applicable
- High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA)Active, not recruitingNCT06092424Not applicable
- HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)Active, not recruitingNCT06084559Not applicable
- HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)Active, not recruitingNCT06072417Not applicable
- High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)Active, not recruitingNCT06003244Not applicable
- HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)Active, not recruitingNCT05996302Not applicable
- Maximal Exercise Capacity at 2500 m of High AltitudeCompletedNCT05264324Not applicable
- Visa-versa! Breaking Instead of Pushing the Pedals-ACompletedNCT05186987Not applicable
- Exercise Endurance Time on the 2nd Day at 2500 m High AltitudeCompletedNCT05131737Not applicable
- Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500mCompletedNCT05112172Not applicable
- Altitude Related Adverse Health Effects (ARAHE) in Patients With Precapillary Pulmonary Hypertension During 30h Exposure to 2500mCompletedNCT05107700Not applicable
- Nocturnal Oxygenation and Sleep-related Breathing Disorders During the First Night of a Stay at 2500m of High Altitude in Patients With Precapillary Pulmonary HypertensionCompletedNCT05089487Not applicable
- Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary HypertensionCompletedNCT04715113Not applicable
- Hemodynamic Effects During Exercise in Patients With Pulmonary Hypertension Receiving SildenafilCompletedNCT04706546Not applicable
- Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without SildenafilCompletedNCT04704440Not applicable
- Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary HypertensionCompletedNCT04697875Not applicable
- Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension Receiving SildenafilCompletedNCT04697862Not applicable
- Acute Exposure of High Altitude on Cardiac OutputCompletedNCT03637218Not applicable
- Acute Exposure of High Altitude on Cognitive FunctionCompletedNCT03637192Not applicable
- Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo) Under ExerciseCompletedNCT03637179Not applicable
- Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo)CompletedNCT03637166Not applicable
- Acute Exposure to High Altitude on Exercise CapacityCompletedNCT03637153Not applicable
- Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo) Under ExerciseCompletedNCT03637140Not applicable
- Acute Exposure of Simulated Hypoxia on Cognitive FunctionCompletedNCT03637127Not applicable
- Acute Exposure of Simulated Hypoxia on Blood and Tissue Oxygenation (aBGA, NIRS)CompletedNCT03637114Not applicable
- Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo)CompletedNCT03637088Not applicable
- Acute Exposure to High Altitude on Blood and Tissue Oxygenation (ABGA, NIRS)CompletedNCT03600415Not applicable
- Acute Exposure to High Altitude on Heart Rate and Ventilation During ExerciseCompletedNCT03593096Not applicable
- Acute Excposure of High Altitude on ECG and Non-invasive Blood Pressure.CompletedNCT03593083Not applicable
- Acute Exposure to High Altitude on SymptomsCompletedNCT03593005Not applicable
- Acute Exposure of Simulated Hypoxia on Heart Rate and Ventilation During ExerciseCompletedNCT03592979Not applicable
- Acute Exposure to Simulated Hypoxia on Exercise CapacityCompletedNCT03592927Not applicable
- Acute Exposure of Simulated Hypoxia on ECG and Non-invasive Blood PressureCompletedNCT03581851Not applicable
- Acute Exposure of Simulated Hypoxia on Cardiac OutputCompletedNCT03574675Not applicable
- Retrospective Data Analysis of Data From the Zurich PH RegistryCompletedNCT03198910
- Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary HypertensionCompletedNCT03195959
- Cerebral Tissue Oxygenation in Highlanders/LowlandersCompletedNCT03172429
- Right Ventricular Function at Rest in Highlanders/LowlandersCompletedNCT03165656
- Right Ventricular Function During Exercise in Highlanders/LowlandersCompletedNCT03165032
- Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.CompletedNCT03165019
- Chronic Clinical Effect of AcetazolamideCompletedNCT02755298Phase 2/3
- Acute Hemodynamic Effect of Acetazolamide in Pulmonary HypertensionCompletedNCT02755259Phase 2/3
- Effect of Exercise Training in Patients With Pulmonary HypertensionStatus unknownNCT02558582Not applicable
- Zürich Pulmonary Hypertension Outcome Assessment CohortStatus unknownNCT02249806
- Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and SleepStatus unknownNCT02150616Phase 4
- Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise PerformanceCompletedNCT02143687Phase 4
- Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary HypertensionCompletedNCT01884012Phase 3
- Effect of Short-term Oxygen During CPET in Pulmonary HypertensionCompletedNCT01748474Phase 2
- Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz HighlandersCompletedNCT01621061
- Smoking: a Risk Factor for Pulmonary Arterial Hypertension?CompletedNCT01484899
- Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary HypertensionCompletedNCT01463514Not applicable
- Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary HypertensionCompletedNCT01427192Phase 2
- Prevention of High Altitude Pulmonary EdemaCompletedNCT00274430Phase 1/2